Vivanza Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
For the full year, sales was INR 104 million compared to INR 98.88 million a year ago. Revenue was INR 112.29 million compared to INR 103.94 million a year ago. Net income was INR 3.33 million compared to INR 0.754 million a year ago. Basic earnings per share from continuing operations was INR 0.83 compared to INR 0.19 a year ago. Diluted earnings per share from continuing operations was INR 0.83 compared to INR 0.19 a year ago.